MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
53.10
-0.02 (-0.04%)
At close: Nov 17, 2026, 4:00 PM EST
53.37
+0.27 (0.51%)
After-hours: Nov 17, 2026, 4:15 PM EST

MBX Biosciences Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, MBX Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $95.09. The average 1-year stock price forecast is 79.08% higher than the current stock price, while the lowest is $80 (+50.66%) and the highest is $150 (+182.49%).

Price Target: $95.09 (+79.08%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$80$95.09$88$150
Change+50.66%+79.08%+65.73%+182.49%

Analyst Ratings

The average analyst rating for MBX Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy999889
Buy223333
Hold000000
Sell000000
Strong Sell100000
Total121112111112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Initiates
$90
BuyInitiates$90+69.49%Nov 12, 2026
Unknown Analyst
Oppenheimer
No rating
Oppenheimer
Buy
Reiterates
$80
BuyReiterates$80+50.66%Nov 11, 2026
UBS
UBS
Buy
Maintains
$90
BuyMaintains$90+69.49%Nov 10, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$84
BuyMaintains$84+58.19%Nov 10, 2026
Barclays
Barclays
Buy
Maintains
$88
BuyMaintains$88+65.73%Oct 13, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.48
from -2.38
EPS Next Year
-4.35
from -3.48
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-----
Operating Income
-25.16M-35.31M-68.19M-98.06M-177.65M
Net Income
-26.14M-32.56M-61.92M-86.97M-167.98M
EPS
----2.38-3.48
Free Cash Flow
----81.88M-164.50M
No. Analysts
----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-3.13
Avg-3.48
Low-3.75

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-